What is the equity of Lihit Lab this year?
Lihit Lab has equity of 10.24 B JPY this year.
In 2024, Lihit Lab's equity was 10.24 B JPY, a 1.3% increase from the 10.11 B JPY equity in the previous year.
Lihit Lab's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Lihit Lab's equity is essential for assessing its financial health, stability, and value to shareholders.
Evaluating Lihit Lab's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Lihit Lab's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Fluctuations in Lihit Lab’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Lihit Lab has equity of 10.24 B JPY this year.
The equity of Lihit Lab has increased/decreased by 1.3% increased compared to the previous year.
A high equity is advantageous for investors of Lihit Lab as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
A low equity can be a risk for investors of Lihit Lab, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
An increase in equity of Lihit Lab can strengthen the company's financial position and improve its ability to make investments in the future.
A reduction in equity of Lihit Lab can affect the financial situation of the company and lead to a higher dependence on debt capital.
Some factors that can affect the equity of Lihit Lab include profits, dividend payments, capital increases, and acquisitions.
The equity of Lihit Lab is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
To change equity, Lihit Lab can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
Over the past 12 months, Lihit Lab paid a dividend of 25 JPY . This corresponds to a dividend yield of about 2.23 %. For the coming 12 months, Lihit Lab is expected to pay a dividend of 25 JPY.
The current dividend yield of Lihit Lab is 2.23 %.
Lihit Lab pays a quarterly dividend. This is distributed in the months of March, March, March, March.
Lihit Lab paid dividends every year for the past 20 years.
For the upcoming 12 months, dividends amounting to 25 JPY are expected. This corresponds to a dividend yield of 2.23 %.
Lihit Lab is assigned to the 'Industry' sector.
To receive the latest dividend of Lihit Lab from 5/1/2024 amounting to 25 JPY, you needed to have the stock in your portfolio before the ex-date on 2/28/2024.
The last dividend was paid out on 5/1/2024.
In the year 2023, Lihit Lab distributed 25 JPY as dividends.
The dividends of Lihit Lab are distributed in JPY.
Our stock analysis for Lihit Lab Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lihit Lab Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.